within Pharmacolibrary.Drugs.ATC.B;

model B03AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 8.333333333333333e-07,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B03AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ferrous carbonate is an iron(II) salt formerly used in the treatment of iron-deficiency anemia. Its usage has declined in favor of more soluble iron formulations. It is not commonly employed in modern clinical practice and is not a first-line therapy for anemia due to concerns over efficacy and tolerability.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for an oral dose in adults; no published pharmacokinetic data specific to ferrous carbonate exist, so values are inferred from general oral iron preparations.</p><h4>References</h4><ol><li><p>Junkert, AM, et al., &amp; Pontarolo, R (2024). Pharmacokinetics of oral ciprofloxacin in adult patients: A scoping review. <i>British journal of clinical pharmacology</i> 90(2) 528–547. DOI:<a href=\"https://doi.org/10.1111/bcp.15933\">10.1111/bcp.15933</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37850318/\">https://pubmed.ncbi.nlm.nih.gov/37850318</a></p></li><li><p>Janknegt, R (1990). Drug interactions with quinolones. <i>The Journal of antimicrobial chemotherapy</i> 26 Suppl D 7–29. DOI:<a href=\"https://doi.org/10.1093/jac/26.suppl_d.7\">10.1093/jac/26.suppl_d.7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2286594/\">https://pubmed.ncbi.nlm.nih.gov/2286594</a></p></li><li><p>Akerele, JO, &amp; Okhamafe, AO (1991). Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics. <i>The Journal of antimicrobial chemotherapy</i> 28(1) 87–94. DOI:<a href=\"https://doi.org/10.1093/jac/28.1.87\">10.1093/jac/28.1.87</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1663108/\">https://pubmed.ncbi.nlm.nih.gov/1663108</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B03AA04;
